URACHAL ABNORMALITY

This adverse event was reported 45 times

These drugs are most commonly taken by patients reporting URACHAL ABNORMALITY:

# Drug Count
0 ALISKIREN 16
1 ALISKIREN HEMIFUMARATE 16
2 AMLODIPINE 16
3 HYDROCHLOROTHIAZIDE 16
4 METHYLDOPA 16
5 INDAPAMIDE 15
6 METOPROLOL 15
7 METOPROLOL TARTRATE 15
8 BISOPROLOL FUMARATE 14
9 METFORMIN 13
See all common drugs associated with URACHAL ABNORMALITY

URACHAL ABNORMALITY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 METHYLDOPA 16 0.0032
1 ALISKIREN HEMIFUMARATE 16 0.0027
2 BIVALIRUDIN 1 0.0010
3 INDAPAMIDE 15 0.0008
4 IDARUCIZUMAB 1 0.0007
5 SELUMETINIB 1 0.0006
6 REMIFENTANIL HYDROCHLORIDE 1 0.0004
7 HYDROXYZINE PAMOATE 1 0.0003
8 INSULIN GLARGINE-YFGN 6 0.0003
9 ACARBOSE 1 0.0003
See all drugs enriched for association with URACHAL ABNORMALITY

URACHAL ABNORMALITY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Humanized Monoclonal Antibody Fragment [EPC] 1 0.0007
1 Thiazide-like Diuretic [EPC] 15 0.0003
2 Anti-coagulant [EPC] 1 0.0003
3 alpha-Glucosidase Inhibitor [EPC] 1 0.0002
4 Thiazide Diuretic [EPC] 17 0.0001
5 Insulin [EPC] 3 0.0001
6 Prostaglandin E1 Analog [EPC] 1 0.0001
7 Dihydropyridine Calcium Channel Blocker [EPC] 17 0.0001
8 Insulin Analog [EPC] 15 0.0000
9 Vitamin D [EPC] 7 0.0000
See all drug classes enriched for association with URACHAL ABNORMALITY